| |
|
|
|
Rigel Pharmaceutical
|
|
2.20 -0.01 (-0.45%) |
8/18/2017 4:00pm |
|
Open: |
2.18 |
Pre close: |
2.21 |
Target:
|
2.87
|
|
High: |
2.29 |
Low: |
2.18 |
Resistance:
|
2.46
2.65
|
|
Volume: |
412,352 |
Market Cap: |
273.66M |
Support:
|
2.14
1.78
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.26
 |
MACD |
MACD(12,26):
|
-0.09  |
|
MA(20): |
2.34 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
2.65 |
Stochastic Oscillator |
%K(14,3):
|
24.53 |
|
MA(250): |
2.75 |
%D(3): |
30.32 |
|
Average Volume(K) |
3-Month: |
92270
|
52-Week |
High:
|
4.38 |
|
10-Days: |
28754 |
Low: |
1.94 |
|
RSI |
RSI(14):
|
36.95 |
Change(%): |
-21.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.670 |
Return on Equity (ttm) |
-101.4 |
Shares Out. (M) |
124.39 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-46.2 |
Shares Float (M) |
115.20 |
|
EPS Est. Next Year |
-0.440 |
PEG Ratio |
-0.05 |
% Held by Insiders |
0.40 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
89.80 |
|
Forward EPS |
-0.430 |
Gross Profit (p.s.) |
0.164 |
Shares Short (K) |
3940 |
|
Book Value (p.s.) |
0.690 |
EBITDA (p.s.) |
-0.544 |
P/E |
-3.28 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.19 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-75.27 |
P/S |
2736580096.00 |
|
Operating Margin |
-660.31 |
Levered Free Cash Flow
(M) |
-41.63 |
P/CF |
-3.64 |
|
|
|
|
 |
|
|
|
